Thrasos: Thrasos Strengthens Composition Of Matter Coverage On THR-184 With Japanese Patent Decision

MONTREAL--(www.businesswire.com/">BUSINESS WIRE)--Thrasos Therapeutics, a biotherapeutics company focused on delivering new solutions for kidney disease, announced today that it received notice of a Decision to Grant on an important composition of matter patent from the Japanese Patent Office. This decision covers Application ...